Skip to main content
. 2014 Oct;27(10):359–363. doi: 10.1093/protein/gzu041

Table II.

Intrastriatal injection of the AAV2/1-C4 scFv construct does not accelerate the pathogenic weight loss in HDR6/1 transgenic mice

Treatment Weight loss age of onset (mean week ± SE) Percentage of wild-type body weight at 23 weeks Percent dying by 25 weeks
HD sham females (n = 12) 19.8 ± 0.5 90.4 ± 1.2 27.8
HD-C4 females (n = 7) 19.3 ± 0.8 88.1 ± 1.4 14.3
HD sham males (n = 10) 16.2 ± 0.8 64.2 ± 0.9 50
HD-C4 males (n = 7) 16.1 ± 0.1 64.2 ± 1.3 0